A key pharmacological challenge in the drug's design is balancing glucagon receptor activity to avoid unwanted increases in hepatic glucose production and net hyperglycaemia, which would counteract the glucose-lowering effects of GLP-1 and GIP agonism
Keep a symptom log noting any increased nausea, vomiting, or changes in bowel patternsthis information helps your healthcare team assess whether dosing adjustments are needed
The primary outcomes assessed included lipid profiles, insulin resistance, anthropometric measurements, leptin, serum glucose levels, blood pressure, and inflammatory markers
Work with your HCP to determine the right dose for you
It appears to: improve blood flow by improving the utilization of fatty acids for energy, which can help reduce muscle fatigue, increase oxygen supply to the affected limbs, and improve walking capacity reduce symptoms, such as leg pain (claudication), and improve the walking distance before the onset of pain
The top nutrients to think about are vitamin D, magnesium, glutathione, omega-3s, and antioxidants
